Outcomes Analysis of Textured Versus Smooth Tissue Expanders in Breast Reconstruction.

Research on implant safety in breast reconstruction has grown due to concerns about implant-associated anaplastic large cell lymphoma. Prior studies have linked textured implants with higher risk of this rare malignancy. Smooth implants are now preferred in many clinical settings. However, limited data exists on the safety of smooth tissue expanders. This gap motivated a need for comparative analysis. No prior work had resolved whether smooth expanders offer equivalent safety. The literature lacks robust outcomes data on smooth versus textured tissue expanders. Surgeons require evidence to guide implant selection. This paper contributes by evaluating complication rates and safety profiles.

This study aimed to compare the safety of smooth and textured tissue expanders in breast reconstruction. The specific problem is the lack of evidence on smooth tissue expander safety. Surgeons need data to determine if smooth expanders are as safe as textured ones. The motivation is the rising use of smooth implants due to BIA-ALCL concerns. The study sought to evaluate complication rates in both groups. Researchers wanted to determine if smooth expanders carry similar risks. No prior work had directly compared these devices in this context. The goal was to provide evidence for clinical decision-making.

A retrospective review was conducted at a single institution between 2015 and 2019. The study included 394 patients undergoing tissue expander-based reconstruction. Patients were divided into smooth and textured groups. Demographics and comorbidities were collected for each group. Complications and surgical outcomes were analyzed. Statistical tests included Fisher exact and t tests. The study focused on rates of hematoma, seroma, and infection. Researchers also tracked reoperation and explantation rates.

No significant differences were found in complication rates between the two groups. Hematoma and seroma rates were similar in smooth and textured groups. Wound dehiscence and delayed healing occurred at similar frequencies. Infection and malposition rates were not statistically different. Nipple and mastectomy flap necrosis were equally rare. Reoperation and readmission rates were comparable. No BIA-ALCL cases were identified in either group. Follow-up averaged 19 and 22 months for smooth and textured groups.

The authors suggest that smooth tissue expanders have an equivalent safety profile to textured ones. They propose that smooth expanders do not increase BIA-ALCL risk. The study supports the use of smooth expanders in breast reconstruction. The authors conclude that textured expanders offer no safety advantage. They suggest that textured expanders have no role in current practice. The findings align with the observed absence of BIA-ALCL cases. The study does not propose new clinical guidelines. The authors suggest that smooth expanders may be preferred due to safety concerns.